Trends in Pharmacological Sciences 1992 - Abstracts
| Trends in Pharmacological Sciences 1992 | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| 5-HT: on the psychiatrist's couch. | Pharmaceuticals and cosmetics industries | Briley, Mike, Grahame-Smith, David | |||
| Active enantiomers may cause adverse effects in asthma. | Pharmaceuticals and cosmetics industries | Chapman, I.D., Buchheit, K.H., Manley, P., Morley, J. | |||
| Alzheimer's disease: pathology to potential treatments? (Current Awareness) | Pharmaceuticals and cosmetics industries | Rothwell, Nancy J., Roberts, Gareth W., Royston, M. Claire | |||
| Amiloride: a molecular probe for mechanosensitive channels. | Pharmaceuticals and cosmetics industries | Hamill, Owen P., Lane, John W., McBride, Don W., Jr. | |||
| Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities. (includes related article) | Pharmaceuticals and cosmetics industries | Greengard, Paul, Gandy, Sam | |||
| Angiotensin receptor subtypes in the brain. (includes bibliography) | Pharmaceuticals and cosmetics industries | Steckelings, U. Muscha, Bottari, Serge P., Unger, Thomas | |||
| Anthranoid laxatives and colorectal cancer. | Pharmaceuticals and cosmetics industries | Siegers, Claus-Peter | |||
| A proposal for the classification of sigma binding sites. | Pharmaceuticals and cosmetics industries | Quirion, Remi, Bowen, Wayne D., Itzhak, Yossef, Junien, Jean Louis, Musacchio, Jose M., Rothman, Richard B., Tsung-Ping, Su, Tam, S. William, Taylor, Duncan P. | |||
| A small K+ channel looms large. | Pharmaceuticals and cosmetics industries | Philipson, Louis H., Miller, Richard J. | |||
| A subfamily of 5-HT(sub 1D) receptor genes. (5-Hydroxytryptamine)(includes related article) | Pharmaceuticals and cosmetics industries | Hartig, Paul R., Branchek, Theresa A., Weinshank, Richard L. | |||
| Block and modulation of cardiac Na+ channels by antiarrhythmic drugs, neurotransmitters and hormones. (includes bibliography) | Pharmaceuticals and cosmetics industries | Grant, Augustus O., Wendt, David J. | |||
| Ca2+-induced Ca2+ release and its modulation by cyclic ADP-ribose. (adenosine phosphate) | Pharmaceuticals and cosmetics industries | Galione, Antony | |||
| Ca2+ influx following receptor activation. (response to J. Meldolesi, et al., Trends in Pharmacological Sciences, vol. 12, p. 289, 1991) | Pharmaceuticals and cosmetics industries | Garcia-Sancho, Javier, Alvarez, Javier, Montero, Mayte, Villalobos, Carlos | |||
| Cardiac alpha1-adrenoceptors mediate positive inotropy via myofibrillar sensitization. | Pharmaceuticals and cosmetics industries | Puceat, M., Terzic, A., Clement, O., Scamps, F., Vogel, S.M., Vassort, G. | |||
| Cell death by apoptosis and its protective role against disease. (includes related article) | Pharmaceuticals and cosmetics industries | Bursch, Wilfried, Oberhammer, Franziska, Schulte-Hermann, Rolf | |||
| Cell volume and hormone action. | Pharmaceuticals and cosmetics industries | Haussinger, Dieter, Lang, Florian | |||
| Cloning of the H1 histamine receptor. | Pharmaceuticals and cosmetics industries | Timmerman, H. | |||
| Cytokines and eicosanoids in cancer drug toxicity. | Pharmaceuticals and cosmetics industries | Preziosi, P., Parente, L., Navarra, P. | |||
| Cytokines and neuropathology. | Pharmaceuticals and cosmetics industries | Wahl, Sharon M., Morganti-Kossman, Maria Cristina, Kossman, Thomas | |||
| Designing therapeutically effective 5-lipoxygenase inhibitors. (Cover Story) | Pharmaceuticals and cosmetics industries | McMillan, R.M., Walker, E.R.H. | |||
| Developments in the drug treatment of schizophrenia. (includes related articles) | Pharmaceuticals and cosmetics industries | Reynolds, Gavin P. | |||
| Deviations from receptor theory? (response to M. Keen, Trends in Pharmacological Sciences, vol. 12, p. 371, 1991) | Pharmaceuticals and cosmetics industries | Leff, Paul, Dougall, Iain G., Harper, Diane | |||
| Direct regulation of cardiac Ca2+ channels by G proteins: neither proven nor necessary? | Pharmaceuticals and cosmetics industries | Fischmeister, Rodolphe, Hartzell, H. Criss | |||
| Dopamine receptor nomenclature. | Pharmaceuticals and cosmetics industries | ||||
| Dopamine receptors in the caudate nucleus and memory processes. | Pharmaceuticals and cosmetics industries | Izquierdo, Ivan | |||
| Drugs of abuse: anatomy, pharmacology and function of reward pathways. | Pharmaceuticals and cosmetics industries | Koob, George F. | |||
| Drugs of abuse: behavioral principles, methods and terms. (includes related article) | Pharmaceuticals and cosmetics industries | Stolerman, Ian | |||
| Endogenous bacterial receptors should cause anxiety. | Pharmaceuticals and cosmetics industries | Lummis, Sarah | |||
| Foundations of Pharmacology. (Software Review) (Evaluation) | Pharmaceuticals and cosmetics industries | Bowmer, C.J. | |||
| Functional expression of receptors in microorganisms. | Pharmaceuticals and cosmetics industries | Strosberg, A. Donny, Marullo, Stefano | |||
| Galanin and galanin antagonists: molecular and biochemical perspectives. (includes related article) | Pharmaceuticals and cosmetics industries | Bartfai, Tamas, Fisone, Gilberto, Langel, Ulo | |||
| Genetic approaches to drug dependence. (includes related articles) | Pharmaceuticals and cosmetics industries | Crabbe, John C., Belknap, John K. | |||
| Glutamate receptor channels: novel properties and new clones. (includes related articles) | Pharmaceuticals and cosmetics industries | Seeburg, Peter H., Sommer, Bernd | |||
| Human cytochromes P450: problems and prospects. (includes bibliography) | Pharmaceuticals and cosmetics industries | Gonzalez, Frank J. | |||
| K+ channel openers and 'natural' cardiac protectors. | Pharmaceuticals and cosmetics industries | Escande, Denis, Cavero, Icilio | |||
| Keeping an eye on the I site: imidazoline-preferring receptors. | Pharmaceuticals and cosmetics industries | Michel, Martin C., Ernsberger, Paul | |||
| Lipocortin-1 exhibits novel actions, providing clinical opportunities. | Pharmaceuticals and cosmetics industries | Rothwell, Nancy J., Flower. Rod | |||
| Low-frequency components of cardiovascular variabilities as markers of sympathetic modulation. (includes related article) | Pharmaceuticals and cosmetics industries | Pagani, Massimo, Rimoldi, Ornella, Malliani, Alberto | |||
| Mapping determinants of the substrate selectivities of P450 enzymes by site-directed mutagenesis. | Pharmaceuticals and cosmetics industries | Johnson, Eric F. | |||
| Mechanism of action of taxol. (Current Awareness) | Pharmaceuticals and cosmetics industries | Horwitz, Susan Band | |||
| Mechanism of tetanus toxin in neuronal cell death. (response to G. Bagetta et al., Trends in Pharmacological Sciences, vol. 12, p. 285, 1991)(includes reply) | Pharmaceuticals and cosmetics industries | Bagetta, G., Nistico, G., Bowery, N.G. | |||
| Metabolic polymorphisms affecting activation of toxic and mutagenic arylamines. | Pharmaceuticals and cosmetics industries | Bock, Karl Walter | |||
| Molecular characterization of endothelin receptors. | Pharmaceuticals and cosmetics industries | Yanagisawa, Masashi, Sakurai, Takeshi, Masaki, Tomoh | |||
| Muscarinic receptor-mediated stimulation of adenylyl cyclase. (includes bibliography) | Pharmaceuticals and cosmetics industries | Baumgold, Jesse | |||
| Myocardial preconditioning as the heart's self-protecting response against the consequences of ischaemia. | Pharmaceuticals and cosmetics industries | Wainwright, Cherry L. | |||
| Nerve membrane Na+ channels as targets of insecticides. (includes related article) | Pharmaceuticals and cosmetics industries | Narahashi, Toshio | |||
| Neurobiology of alcohol abuse. (includes related article) | Pharmaceuticals and cosmetics industries | Harris, R. Adron, Samson, Herman H. | |||
| Neurobiology of cocaine abuse. | Pharmaceuticals and cosmetics industries | Woolverton, William L., Johnson, Kenneth M. | |||
| Neurobiology of marijuana abuse. | Pharmaceuticals and cosmetics industries | Abood, Mary E., Martin, Billy R. | |||
| Neurobiology of opiate abuse. (includes related articles) | Pharmaceuticals and cosmetics industries | North, R. Alan, Di Chiara, Gaetano | |||
| Neuroendocrine actions of endothelins. (includes related article) | Pharmaceuticals and cosmetics industries | Stojilkovic, Stanko S., Catt, Kevin J. | |||
| Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. | Pharmaceuticals and cosmetics industries | Moskowitz, Michael A. | |||
| New insights into activation of the steroid hormone receptor superfamily. | Pharmaceuticals and cosmetics industries | O'Malley, Bert W., Power, Ronan F., Conneely, Orla M. | |||
| New mutants to explore nicotinic receptor functions. | Pharmaceuticals and cosmetics industries | Galzi, Jean-Luc, Devillers-Thiery, Anne, Changeux, Jean-Pierre, Bertrand, Daniel | |||
| Nikolai Vasilyevich Lazarev: biographical notes. | Pharmaceuticals and cosmetics industries | ||||
| Nitric oxide takes center-stage with newly defined roles. | Pharmaceuticals and cosmetics industries | Vallance, Patrick, McCall, Therese | |||
| Nonpeptide antagonists herald new era in tachykinin research. | Pharmaceuticals and cosmetics industries | Watling, W.J. | |||
| Nuclear receptors and chemical carcinogenesis. | Pharmaceuticals and cosmetics industries | Green, Stephen | |||
| Nucleoside diphosphate kinases as potential new targets for control of development and cancer. | Pharmaceuticals and cosmetics industries | Lacombe, M.L., Jakobs, K.H. | |||
| Of mice and flies: commonalities among 5-HT receptors. (5-Hydroxytryptamine) | Pharmaceuticals and cosmetics industries | Hen, Rene | |||
| Origin Versions 1.1 and 2.0. (Software Review) (Evaluation) | Pharmaceuticals and cosmetics industries | Weightman, Neil | |||
| Pathogenesis of NSAID gastropathy: are neutrophils the culprits? (nonsteroidal anti-inflammatory drugs) (Current Awareness) | Pharmaceuticals and cosmetics industries | Wallace, John L., Granger, D. Neil | |||
| Peripheral versus central mechanisms in the behavioral effects of cytokines. | Pharmaceuticals and cosmetics industries | ||||
| Pharmacological effects of drug conjugates: is morphine 6-glucuronide an exception? | Pharmaceuticals and cosmetics industries | Mulder, Gerard J. | |||
| Pharmacological prospects for alpha2-adrenoceptor antagonist therapy. | Pharmaceuticals and cosmetics industries | Berlan, Michel, Montastruc, Jean-Luc, Lafontan, Max | |||
| Pharmacology and electrophysiology of ATP-activated ion channels. (adenosine triphosphate) | Pharmaceuticals and cosmetics industries | Bean, Bruce P. | |||
| Psychosocial interventions. (treating alcoholism) | Pharmaceuticals and cosmetics industries | ||||
| Recent advances in the electrophysiological characterization of 5-HT3 receptors. | Pharmaceuticals and cosmetics industries | Peters, John A., Malone, Hilary M., Lambert, Jeremy J. | |||
| Receptor sites for Ca2+ channel antagonists. | Pharmaceuticals and cosmetics industries | Striessnig, Jorg, Catterall, William A. | |||
| Regulation of brain neurotrophin expression by physiological activity. | Pharmaceuticals and cosmetics industries | Gall, Christine M. | |||
| Reverse intrinsic activity of antagonists on G protein-coupled receptors. | Pharmaceuticals and cosmetics industries | Schutz, Wolfgang, Freissmuth, Michael | |||
| Scientific discourse, in public. | Pharmaceuticals and cosmetics industries | Hay, Alastair | |||
| Sequential theories for stomach cancer. (This and That) | Pharmaceuticals and cosmetics industries | Max, B. | |||
| Signal transduction from the extracellular matrix: the integrin-tyrosine kinase connection. | Pharmaceuticals and cosmetics industries | Kornberg, L., Juliano, R.L. | |||
| Structural basis of voltage-gated K+ channel pharmacology. (includes bibliography) | Pharmaceuticals and cosmetics industries | Pongs, Olaf | |||
| Structure and pharmacology of the proton-ATPases. (adenosine triphosphatases)(includes related article) | Pharmaceuticals and cosmetics industries | Nelson, Nathan | |||
| Subunit structure of native GABAA receptors in the mammalian CNS. (gamma-aminobutyric acid; central nervous system) | Pharmaceuticals and cosmetics industries | ||||
| The 5-HT(sub 4) receptor: a place in the sun. (5-hydroxytryptamine) | Pharmaceuticals and cosmetics industries | Bockaert, Joel, Fozard, John R., Dumuis, Aline, Clarke, David E. | |||
| The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands. | Pharmaceuticals and cosmetics industries | Gustafsson, Jan-Ake, Poellinger, Lorenz, Gottlicher, Martin | |||
| The genetic basis of malignant hyperthermia. (includes related article) | Pharmaceuticals and cosmetics industries | MacLennan, David H. | |||
| The influence of endocardial endothelium on myocardial contraction. | Pharmaceuticals and cosmetics industries | Smith, Jerry A., Shah, Ajay M., Fort, Steve, Lewis, Malcolm J. | |||
| The multiple applications of isotopic ratios. (This and That) | Pharmaceuticals and cosmetics industries | Max, B. | |||
| Therapeutic potential of cytokine manipulation. | Pharmaceuticals and cosmetics industries | Henderson, Brian, Blake, Simon | |||
| The three eras in experimental toxicology. (includes related article) | Pharmaceuticals and cosmetics industries | Zbinden, G. | |||
| This and that: an artefactual alkaloid and its peptide analogs. (includes bibliography) | Pharmaceuticals and cosmetics industries | Max, B. | |||
| This and that: creatine's superfluous methyl and the shadowed art of Cimabue. (Florentine fresco artist Cenni di Pepi) | Pharmaceuticals and cosmetics industries | Max, B. | |||
| This and that: hair pigments, the hypoxic basis of life and the Virgilian journey of the spermatozoon. | Pharmaceuticals and cosmetics industries | Max, B. | |||
| This and that: the essential pharmacology of herbs and spices. | Pharmaceuticals and cosmetics industries | Max, B. | |||
| Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability. (examining opioid abuse liability) | Pharmaceuticals and cosmetics industries | Woods, J.H., Winger, G., France, C.P. | |||
| Will the real NMDA receptor please stand up? | Pharmaceuticals and cosmetics industries | Barnard, Eric | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.